Market Tracker

05/26 5:16pm ET

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

9.35
Delayed Data
As of May 26
 +0.05 / +0.54%
Today’s Change
8.55
Today|||52-Week Range
15.03
-13.43%
Year-to-Date
No recent news for SciClone Pharmaceuticals Inc.

Today’s Trading

Previous close9.30
Today’s open9.35
Day’s range9.18 - 9.45
Volume112,716
Average volume (3 months)227,203
Market cap$481.1M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+3.57%
Earnings growth (this year)+58.62%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+1.81%
P/E ratio13.2
Price/Sales3.55
Price/Book2.21

Competitors

 Today’s
change
Today’s
% change
SPPISpectrum Pharmaceuti...-0.17-2.87%
PGNXProgenics Pharmaceut...-0.20-2.95%
SCMPSucampo Pharmaceutic...-0.25-2.38%
GTHXG1 Therapeutics Inc+0.43+2.56%
Data as of 4:00pm ET, 05/26/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$160.1M
Annual profit (last year)$30.7M
Net profit margin19.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer &
Senior VP-Finance
Wai-Shun Cheung
Corporate headquarters
Foster City, California

Forecasts